Kopran Limited has informed the Exchange for Investor presentation on Q1 FY2025-26 results
KOPRAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kopran Limited filed its Q1 FY2025-26 investor presentation with the exchanges. Revenue from operations stood at Rs. 13,522 lakhs, down about 3% year-on-year from Rs. 13,944 lakhs in Q1 FY24-25 and down sharply from Rs. 17,236 lakhs in the preceding quarter. Net profit fell to Rs. 745 lakhs, a steep ~33% decline from Rs. 1,110 lakhs in the same quarter last year. EBITDA margin contracted to 10.45% from 13.03% a year ago, with EBITDA at Rs. 1,413 lakhs versus Rs. 1,816 lakhs. The company, which operates API and Formulations verticals and exports to 50+ countries, highlighted strategic focus on R&D, capacity expansion at Panoli, and reducing dependence on China for intermediates.
The Q1 results show a clear deterioration in profitability with both revenue and margins slipping year-on-year, which is likely to weigh negatively on investor sentiment in the near term. However, management's focus on cost optimisation, new regulatory filings, and a new API/R&D facility at Panoli could support a gradual recovery if execution stays on track.